Skip to Content

1122 (Qtern dapagliflozin 10 mg / saxagliptin 5 mg)

Generic Name: dapagliflozin/saxagliptin

Pill with imprint 1122 is Brown, Round and has been identified as Qtern dapagliflozin 10 mg / saxagliptin 5 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Qtern is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Qtern dapagliflozin 10 mg / saxagliptin 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 1122

Qtern

Generic Name:
dapagliflozin/saxagliptin
Imprint:
1122
Strength:
dapagliflozin 10 mg / saxagliptin 5 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC):
00310-6780

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide